A nearly calorie-free sugar substitute that does not raise blood sugar or insulin, is gentler on digestion than other sugar alcohols, and helps protect teeth. Replacing sugar with it also cuts calories. The main downside is digestive upset from large amounts; a debated link to heart and clotting problems remains unresolved. (Full Review)

Protocol

Use

1:1 sugar swap

~1.3× volume to match sweetness (60–80% as sweet as sugar)

Timing

Any meal, with food

No time-of-day requirement; food improves tolerance

Dosing

Split across meals

Avoid large single servings to limit spikes and upset

Time to effect

Blood sugar

Immediate

Blood-sugar neutrality at each use

Dental

Months

Builds over consistent sugar replacement

Weight

Gradual

Consistent with reduced calorie intake

Benefits

High: No rise in blood sugar or insulin; best digestive tolerability among sugar alcohols; dental and oral health protection

Medium: Calorie reduction and weight management

Low: Vascular and endothelial function in diabetes; direct antioxidant activity; appetite and satiety signaling

Speculative: Oral microbiome and prebiotic effects

Contraindications

Documented erythritol allergy

Key Interactions

Antiplatelet/anticoagulant drugs (aspirin, clopidogrel, warfarin)

OTC products containing sugar alcohols (antacids, cough syrups, lozenges)

Other sugar alcohols (xylitol, sorbitol, maltitol, mannitol) and prebiotic fibers (inulin)

Active irritable bowel syndrome or chronic diarrhea

Established cardiovascular disease or high clotting-risk profile

Risk & Side Effects

High: Gastrointestinal distress at high intake

Medium: Cardiovascular events and enhanced thrombosis

Low: Hypersensitivity and allergic reactions

Speculative: Association with weight gain and cardiometabolic risk

Monitoring

Marker	Target	Why
Fasting glucose	70–90 mg/dL	Confirms sugar substitution is helping glucose control
Glycated hemoglobin (HbA1c)	< 5.4%	Tracks average blood sugar over ~3 months
High-sensitivity C-reactive protein (hs-CRP)	< 1.0 mg/L	General marker of inflammation and cardiovascular risk
Fasting lipid panel	Triglycerides < 80 mg/dL; HDL > 50 mg/dL	Contextualizes cardiometabolic risk relevant to the erythritol debate
Estimated glomerular filtration rate (eGFR)	> 90 mL/min/1.73m²	Reflects kidney function, the route of erythritol clearance

Cadence: Baseline, 3 months, then every 6–12 months

Qualitative Assessment

Digestive comfort: absence of bloating, gas, or loose stools at the chosen intake level
Energy and cravings: steadier energy and reduced sugar cravings after replacing sugar
Dental health: fewer cavities and improved dental-checkup outcomes over time
Weight trend: gradual change consistent with reduced caloric intake from sweeteners

Erythritol for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment